[1]
Lagier JC, Edouard S, Pagnier I, Mediannikov O, Drancourt M, Raoult D. Current and past strategies for bacterial culture in clinical microbiology. Clinical microbiology reviews. 2015 Jan:28(1):208-36. doi: 10.1128/CMR.00110-14. Epub
[PubMed PMID: 25567228]
[2]
Sawatzky P, Liu G, Dillon JA, Allen V, Lefebvre B, Hoang L, Tyrrell G, Van Caeseele P, Levett P, Martin I. Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012. Journal of clinical microbiology. 2015 Nov:53(11):3646-9. doi: 10.1128/JCM.02303-15. Epub 2015 Sep 2
[PubMed PMID: 26338862]
Level 2 (mid-level) evidence
[3]
Graham DR, Dixon RE, Hughes JM, Thornsberry C. Disk diffusion antimicrobial susceptibility testing for clinical and epidemiologic purposes. American journal of infection control. 1985 Dec:13(6):241-9
[PubMed PMID: 3936382]
[4]
Humphries RM. Update on Susceptibility Testing: Genotypic and Phenotypic Methods. Clinics in laboratory medicine. 2020 Dec:40(4):433-446. doi: 10.1016/j.cll.2020.08.002. Epub 2020 Sep 30
[PubMed PMID: 33121613]
[5]
Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Mitic Culafic D, Trudic A, Ranin L, Opavski N. Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods. Antibiotics (Basel, Switzerland). 2022 Mar 23:11(4):. doi: 10.3390/antibiotics11040427. Epub 2022 Mar 23
[PubMed PMID: 35453179]
[6]
Coorevits L, Boelens J, Claeys G. Direct susceptibility testing by disk diffusion on clinical samples: a rapid and accurate tool for antibiotic stewardship. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2015 Jun:34(6):1207-12. doi: 10.1007/s10096-015-2349-2. Epub 2015 Feb 20
[PubMed PMID: 25698312]
[7]
Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X, Liang L, Dharan N, Cho SN, Barry CE 3rd, Ellner JJ, Dorman SE, Alland D. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. The New England journal of medicine. 2017 Sep 14:377(11):1043-1054. doi: 10.1056/NEJMoa1614915. Epub
[PubMed PMID: 28902596]
[8]
Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis. 2016 Apr:6(2):71-79. doi: 10.1016/j.jpha.2015.11.005. Epub 2015 Dec 2
[PubMed PMID: 29403965]
[9]
Kowalska-Krochmal B, Dudek-Wicher R. The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens (Basel, Switzerland). 2021 Feb 4:10(2):. doi: 10.3390/pathogens10020165. Epub 2021 Feb 4
[PubMed PMID: 33557078]
[10]
Nassar MSM, Hazzah WA, Bakr WMK. Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be? The Journal of the Egyptian Public Health Association. 2019:94(1):4. doi: 10.1186/s42506-018-0006-1. Epub 2019 Jan 11
[PubMed PMID: 30686832]
[11]
Salam MA, Al-Amin MY, Pawar JS, Akhter N, Lucy IB. Conventional methods and future trends in antimicrobial susceptibility testing. Saudi journal of biological sciences. 2023 Mar:30(3):103582. doi: 10.1016/j.sjbs.2023.103582. Epub 2023 Feb 10
[PubMed PMID: 36852413]
[12]
Andrews JM. Determination of minimum inhibitory concentrations. The Journal of antimicrobial chemotherapy. 2001 Jul:48 Suppl 1():5-16
[PubMed PMID: 11420333]
[13]
King A, Brown DF. Quality assurance of antimicrobial susceptibility testing by disc diffusion. The Journal of antimicrobial chemotherapy. 2001 Jul:48 Suppl 1():71-6
[PubMed PMID: 11420339]
Level 2 (mid-level) evidence
[14]
Hong SK, Choi SJ, Shin S, Lee W, Pinto N, Shin N, Lee K, Hong SG, Kim YA, Lee H, Kim H, Song W, Lee SH, Yong D, Lee K, Chong Y. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories. Annals of laboratory medicine. 2015 Nov:35(6):635-8. doi: 10.3343/alm.2015.35.6.635. Epub
[PubMed PMID: 26354353]
Level 2 (mid-level) evidence
[15]
Sharp SE, Elder BL. Competency assessment in the clinical microbiology laboratory. Clinical microbiology reviews. 2004 Jul:17(3):681-94, table of contents
[PubMed PMID: 15258098]
[16]
Desjardins M, Fleming CA. Competency assessment of microbiology medical laboratory technologists in Ontario, Canada. Journal of clinical microbiology. 2014 Aug:52(8):2940-5. doi: 10.1128/JCM.01035-14. Epub 2014 Jun 4
[PubMed PMID: 24899030]
[17]
Henderson A, Bursle E, Stewart A, Harris PNA, Paterson D, Chatfield MD, Paul M, Dickstein Y, Rodriguez-Baño J, Turnidge JD, Kahlmeter G. A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to gram-negative pathogens. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021 Dec:27(12):1746-1753. doi: 10.1016/j.cmi.2021.03.019. Epub 2021 Apr 1
[PubMed PMID: 33813125]
Level 1 (high-level) evidence
[18]
Wu H, Lutgring JD, McDonald LC, Webb A, Fields V, Blum L, Mojica M, Edwards J, Soe MM, Pollock DA. Selective and Cascade Reporting of Antimicrobial Susceptibility Testing Results and Its Impact on Antimicrobial Resistance Surveillance-National Healthcare Safety Network, April 2020 to March 2021. Microbiology spectrum. 2023 Jan 31:11(2):e0164622. doi: 10.1128/spectrum.01646-22. Epub 2023 Jan 31
[PubMed PMID: 36719248]
[19]
Chaitram JM, Jevitt LA, Lary S, Tenover FC, WHO Antimicrobial Resistancce Group. The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods. Journal of clinical microbiology. 2003 Jun:41(6):2372-7
[PubMed PMID: 12791851]
Level 2 (mid-level) evidence
[20]
Wattal C, Oberoi JK, Goel N, Datta S, Raveendran R, Prasad KJ. Experience of Indian association of medical microbiology external quality assurance scheme centre, New Delhi: Challenges and quality assessment of clinical microbiology laboratories. Indian journal of medical microbiology. 2019 Apr-Jun:37(2):163-172. doi: 10.4103/ijmm.IJMM_19_356. Epub
[PubMed PMID: 31745015]
Level 2 (mid-level) evidence
[21]
Santos DA, Barros ME, Hamdan JS. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. Journal of clinical microbiology. 2006 Jan:44(1):98-101
[PubMed PMID: 16390955]
[22]
Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clinic proceedings. 2011 Feb:86(2):156-67. doi: 10.4065/mcp.2010.0639. Epub
[PubMed PMID: 21282489]
[23]
Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clinical microbiology reviews. 2007 Jul:20(3):391-408, table of contents
[PubMed PMID: 17630331]
[24]
Kassim A, Omuse G, Premji Z, Revathi G. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study. Annals of clinical microbiology and antimicrobials. 2016 Apr 11:15():21. doi: 10.1186/s12941-016-0135-3. Epub 2016 Apr 11
[PubMed PMID: 27068515]
Level 2 (mid-level) evidence
[25]
Diekema DJ, Lee K, Raney P, Herwaldt LA, Doern GV, Tenover FC. Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. Journal of clinical microbiology. 2004 May:42(5):2258-60
[PubMed PMID: 15131206]
[26]
Wu Y, Wang Q, Zheng F, Yu T, Wang Y, Fan S, Zhang X. The Sample Error Pre-Antimicrobial Susceptibility Testing and Its Influencing Factors from the Perspective of Hospital Management: A Cross-Sectional Study. Antibiotics (Basel, Switzerland). 2022 Nov 28:11(12):. doi: 10.3390/antibiotics11121715. Epub 2022 Nov 28
[PubMed PMID: 36551371]
Level 2 (mid-level) evidence
[27]
Rojo-Molinero E, Alados JC, de la Pedrosa EG, Leiva J, Pérez JL. [Safety in the Microbiology laboratory]. Enfermedades infecciosas y microbiologia clinica. 2015 Jun-Jul:33(6):404-10. doi: 10.1016/j.eimc.2014.06.014. Epub 2014 Nov 8
[PubMed PMID: 25444041]
[28]
Liu W, Liao K, Wu J, Liu S, Zheng X, Wen W, Fu L, Fan X, Yang X, Hu X, Jiang Y, Wu K, Guo Z, Li Y, Liu W, Cai M, Guo Z, Guo X, Lu J, Chen E, Zhou H, Chen D. Blood culture quality and turnaround time of clinical microbiology laboratories in Chinese Teaching Hospitals: A multicenter study. Journal of clinical laboratory analysis. 2024 Jan:38(1-2):e25008. doi: 10.1002/jcla.25008. Epub 2024 Jan 18
[PubMed PMID: 38235610]
Level 2 (mid-level) evidence
[29]
Kim JH, Kim I, Kang CK, Jun KI, Yoo SH, Chun JY, Jung J, Kim YJ, Kim DY, Jo HB, Kim DY, Koh Y, Shin DY, Hong J, Kim NJ, Yoon SS, Kim TS, Park WB, Oh MD. Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021 Jan:27(1):69-75. doi: 10.1016/j.cmi.2020.03.038. Epub 2020 Apr 6
[PubMed PMID: 32272171]
Level 1 (high-level) evidence
[30]
Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N. A Review on Antibiotic Resistance: Alarm Bells are Ringing. Cureus. 2017 Jun 28:9(6):e1403. doi: 10.7759/cureus.1403. Epub 2017 Jun 28
[PubMed PMID: 28852600]
[31]
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P & T : a peer-reviewed journal for formulary management. 2015 Apr:40(4):277-83
[PubMed PMID: 25859123]
[32]
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MKF, Baloch Z. Antibiotic resistance: a rundown of a global crisis. Infection and drug resistance. 2018:11():1645-1658. doi: 10.2147/IDR.S173867. Epub 2018 Oct 10
[PubMed PMID: 30349322]
[33]
Rather IA, Kim BC, Bajpai VK, Park YH. Self-medication and antibiotic resistance: Crisis, current challenges, and prevention. Saudi journal of biological sciences. 2017 May:24(4):808-812. doi: 10.1016/j.sjbs.2017.01.004. Epub 2017 Jan 9
[PubMed PMID: 28490950]